These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Maple syrup urine disease. Two cases in Israel. Chemke J; Levin S Isr J Med Sci; 1975 Aug; 11(8):809-16. PubMed ID: 1165176 [TBL] [Abstract][Full Text] [Related]
27. The therapy of maple syrup urine disease. Snyderman SE Am J Dis Child; 1967 Jan; 113(1):68-73. PubMed ID: 6015908 [No Abstract] [Full Text] [Related]
28. Comparison of exchange transfusion, peritoneal dialysis, and hemodialysis for the treatment of hyperammonemia in an anuric newborn infant. Donn SM; Swartz RD; Thoene JG J Pediatr; 1979 Jul; 95(1):67-70. PubMed ID: 480015 [No Abstract] [Full Text] [Related]
29. Continuous veno-venous hemodiafiltration in neonates with maple syrup urine disease. Deger İ; Çelik M; Taş İ; Samancı S Ther Apher Dial; 2022 Jun; 26(3):658-666. PubMed ID: 35166449 [TBL] [Abstract][Full Text] [Related]
30. [Maple Syrup Urine Disease in a newborn infant]. Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467 [TBL] [Abstract][Full Text] [Related]
31. Management of acute metabolic decompensation in maple syrup urine disease: a multi-center study. Yoshino M; Aoki K; Akeda H; Hashimoto K; Ikeda T; Inoue F; Ito M; Kawamura M; Kohno Y; Koga Y; Kuroda Y; Maesaka H; Murakamisoda H; Sugiyama N; Suzuki Y; Yano S; Yoshioka A Pediatr Int; 1999 Apr; 41(2):132-7. PubMed ID: 10221014 [TBL] [Abstract][Full Text] [Related]
32. [Simple and rapid determination of leucine by HPLC. Importance for extra-renal treatment of maple syrup urine disease]. Garcia J; Galinier A; Periquet B; Broué P; Decramer S; Thouvenot JP; Caspar-Bauguil S Ann Biol Clin (Paris); 2002; 60(5):602-6. PubMed ID: 12368147 [No Abstract] [Full Text] [Related]
33. Maple syrup urine disease--therapeutic use of insulin in catabolic states. Wendel U; Langenbeck U; Lombeck I; Bremer HJ Eur J Pediatr; 1982 Nov; 139(3):172-5. PubMed ID: 6761134 [TBL] [Abstract][Full Text] [Related]
34. [Mid-term outcome of 2 cases with maple syrup urine disease: role of liver transplantation in the treatment]. Netter JC; Cossarizza G; Narcy C; Hubert P; Ogier H; Revillon Y; Rabier D; Saudubray JM Arch Pediatr; 1994 Aug; 1(8):730-4. PubMed ID: 7842107 [TBL] [Abstract][Full Text] [Related]
35. The treatment of maple syrup urine disease. Goodman SI; Pollak S; Miles B; O'Brien D J Pediatr; 1969 Sep; 75(3):485-8. PubMed ID: 5804198 [No Abstract] [Full Text] [Related]
37. MAPLE SYRUP URINE DISEASE. REPORT OF THE FIRST CASE IN PUERTO RICO. JIMENEZ AI; SIFONTES JE; SANCHEZLONGO LP Bol Asoc Med P R; 1963 Nov; 55():463-8. PubMed ID: 14112942 [No Abstract] [Full Text] [Related]
38. [On prolonged diet-therapy of an infant with urinary valine and leucine disorders associated with mental retardation (maple syrup urine disease)]. Schmidt GW; Benecke G; Peiffer J Helv Paediatr Acta; 1965 Jun; 20(2):147-68. PubMed ID: 5834532 [No Abstract] [Full Text] [Related]
39. [Continuous arteriovenous hemofiltration. Management in case of neonatal leucinosis]. Casadevall I; Ogier H; Germain JF; Daoud P; Hartmann JF; Mercier JC; Beaufils F Arch Fr Pediatr; 1992 Nov; 49(9):803-5. PubMed ID: 1300969 [TBL] [Abstract][Full Text] [Related]